Drishty Satpati
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Cationic amino acid-engineered radiopeptides for breast cancer targeting.
Journal: Bioorganic & medicinal chemistry
Published: June 17, 2026
Influence of Peptide-Based Chelator Sequences on HER2-Targeting Radiopeptide.
Journal: Journal of peptide science : an official publication of the European Peptide Society
Published: January 20, 2026
Redox investigation of L-A9 peptide and evaluation of its binding with double stranded DNA.
Journal: Scientific reports
Published: September 24, 2025
Diagnostic performance of 99mTc-PSMA SPECT/CT in primary prostate carcinoma.
Journal: World journal of clinical cases
Published: March 26, 2025
Cancer Targeting Radiopeptidomimetics in Molecular Nuclear Medicine.
Journal: Molecular pharmaceutics
Published: March 13, 2025
99mTc-HYNIC PEGylated Peptide Probe Targeting HER2-Expression in Breast Cancer.
Journal: Chemical biology & drug design
Published: December 04, 2024
Unlocking the power of affibody conjugated radioactive metallopharmaceuticals for targeted cancer diagnosis and therapy.
Journal: Pharmacology & therapeutics
Published: October 28, 2024
Influence of PEGylation on HER2-targeting retro A9 peptide analogue.
Journal: Nuclear medicine and biology
Published: July 05, 2024
177Lu-labeling of nuclear localization sequence (NLS)-grafted HER2-receptor affine peptide.
Journal: Bioorganic & medicinal chemistry
Published: July 01, 2024
Nuclear Localization Signal Enhances the Targeting and Therapeutic Efficacy of a Porphyrin-Based Molecular Cargo: A Systemic In Vitro and Ex Vivo Evaluation.
Journal: Molecular pharmaceutics
Published: March 13, 2024
Peptide-drug conjugate designated for targeted delivery to HER2-expressing cancer cells.
Journal: Journal of peptide science : an official publication of the European Peptide Society
Published: January 16, 2024
Synthesis and 177Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior Variant.
Journal: Bioconjugate chemistry
Published: June 28, 2023
Last Updated: 09/26/2026